Ketamine hydrochlorideCAS# 1867-66-9 |
2D Structure
- Rocilinostat (ACY-1215)
Catalog No.:BCC2144
CAS No.:1316214-52-4
- LY 294002
Catalog No.:BCC3659
CAS No.:154447-36-6
- (±)-Bay K 8644
Catalog No.:BCC3918
CAS No.:71145-03-4
- Omeprazole
Catalog No.:BCC1254
CAS No.:73590-58-6
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 1867-66-9 | SDF | Download SDF |
PubChem ID | 15851 | Appearance | Powder |
Formula | C13H17Cl2NO | M.Wt | 274.19 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mM in water | ||
Chemical Name | 2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one;hydrochloride | ||
SMILES | CNC1(CCCCC1=O)C2=CC=CC=C2Cl.Cl | ||
Standard InChIKey | VCMGMSHEPQENPE-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C13H16ClNO.ClH/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14;/h2-3,6-7,15H,4-5,8-9H2,1H3;1H | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Non-competitive NMDA receptor antagonist (EC50 values are 13.6 and 17.6 μM for NR1/NR2A and NR1/NR2B subunit combinations respectively). Dissociative anesthetic. S-enantiomer also available. |
Ketamine hydrochloride Dilution Calculator
Ketamine hydrochloride Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.6471 mL | 18.2355 mL | 36.4711 mL | 72.9421 mL | 91.1777 mL |
5 mM | 0.7294 mL | 3.6471 mL | 7.2942 mL | 14.5884 mL | 18.2355 mL |
10 mM | 0.3647 mL | 1.8236 mL | 3.6471 mL | 7.2942 mL | 9.1178 mL |
50 mM | 0.0729 mL | 0.3647 mL | 0.7294 mL | 1.4588 mL | 1.8236 mL |
100 mM | 0.0365 mL | 0.1824 mL | 0.3647 mL | 0.7294 mL | 0.9118 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- H-D-Tyr(tBu)-OH
Catalog No.:BCC3137
CAS No.:186698-58-8
- Roscovitine (Seliciclib,CYC202)
Catalog No.:BCC1105
CAS No.:186692-46-6
- 2-NBDG
Catalog No.:BCC6530
CAS No.:186689-07-6
- 4-Methylcinnamic acid
Catalog No.:BCN5034
CAS No.:1866-39-3
- Allyl cinnamate
Catalog No.:BCC8812
CAS No.:1866-31-5
- 1,2-Bis(3-indenyl)ethane
Catalog No.:BCC8413
CAS No.:18657-57-3
- LY 344864
Catalog No.:BCC1716
CAS No.:186544-26-3
- Zibotentan (ZD4054)
Catalog No.:BCC2524
CAS No.:186497-07-4
- Alisol B
Catalog No.:BCN3364
CAS No.:18649-93-9
- Actein
Catalog No.:BCN1159
CAS No.:18642-44-9
- Psoralidin
Catalog No.:BCN5414
CAS No.:18642-23-4
- CP 316819
Catalog No.:BCC6039
CAS No.:186392-43-8
- N6-methyladenosine (m6A)
Catalog No.:BCC6495
CAS No.:1867-73-8
- Alisol A 24-acetate
Catalog No.:BCN2344
CAS No.:18674-16-3
- Ginsenoside Rg5
Catalog No.:BCN3551
CAS No.:186763-78-0
- ML 10302 hydrochloride
Catalog No.:BCC7695
CAS No.:186826-17-5
- Moxifloxacin HCl
Catalog No.:BCC2507
CAS No.:186826-86-8
- 2B-(SP)
Catalog No.:BCC5817
CAS No.:186901-17-7
- Pafuramidine
Catalog No.:BCC1832
CAS No.:186953-56-0
- Sinapine
Catalog No.:BCN1815
CAS No.:18696-26-9
- N,N'-Bis(2-hydroxyethyl)oxamide
Catalog No.:BCC9061
CAS No.:1871-89-2
- NS309
Catalog No.:BCC1809
CAS No.:18711-16-5
- Clauszoline M
Catalog No.:BCN4683
CAS No.:187110-72-1
- Luliconazole
Catalog No.:BCC1711
CAS No.:187164-19-8
Comparison of different administration of ketamine and intravenous tramadol hydrochloride for postoperative pain relief and sedation after pediatric tonsillectomy.[Pubmed:25569408]
J Craniofac Surg. 2015 Jan;26(1):e21-4.
OBJECTIVES: Tonsillectomy is the oldest and most frequently performed surgical procedure practiced by ear, nose, and throat physicians. In this study, our aim was to compare the analgesic effects of peritonsillar, rectal, as well as intravenous infiltration of ketamine and intravenous tramadol hydrochloride infiltration for postoperative pain relief and sedation after tonsillectomy in children. MATERIALS AND METHODS: This randomized controlled study evaluated the effects of peritonsillar, intravenous, and rectal infiltration of ketamine in children undergoing adenotonsillectomy. One hundred twenty children who were categorized under American Society of Anesthesiologists classes I to II were randomized to 4 groups of 30 members each. Group 1 received intravenous (IV) ketamine (0.5 mg/kg), group 2 received rectal ketamine (0.5 mg/kg), group 3 received local peritonsillar ketamine (2 mg/kg), and the control group received IV tramadol hydrochloride infiltration (2 mg/kg). Children's Hospital of Eastern Ontario Pain Scale scores and Wilson sedation scale were recorded at minutes 1, 15, 30, 60 as well as hours 2, 12, and 24 postoperatively. The patients were interviewed on the day after the surgery to assess the postoperative pain and sedation. RESULTS: All the routes of infiltration of ketamine were as effective as those of tramadol hydrochloride (P > 0.05). A statistically significant difference was observed between IV infiltrations and all groups during the assessments at hours 6 and 24. The analgesic efficacy of IV ketamine was found especially higher at hours 6 and 24 (P(6) = 0.045, P(24) = 0.011). CONCLUSIONS: Perioperative, low-dose IV, rectal, or peritonsillar ketamine infiltration provides efficient pain relief without any adverse effects in children who would undergo adenotonsillectomy.
Effects of anesthetic induction with a benzodiazepine plus ketamine hydrochloride or propofol on hypothermia in dogs undergoing ovariohysterectomy.[Pubmed:27027833]
Am J Vet Res. 2016 Apr;77(4):351-7.
OBJECTIVE: To assess the effect of anesthetic induction with a benzodiazepine plus ketamine or propofol on hypothermia in dogs undergoing ovariohysterectomy without heat support. ANIMALS: 23 adult sexually intact female dogs undergoing ovariohysterectomy. PROCEDURES: Baseline rectal temperature, heart rate, and respiratory rate were recorded prior to premedication with buprenorphine (0.02 mg/kg, IM) and acepromazine (0.05 mg/kg, IM). Anesthesia was induced with midazolam or diazepam (0.25 mg/kg, IV) plus ketamine (5 mg/kg, IV; n = 11) or propofol (4 mg/kg, IV; 12) and maintained with isoflurane in oxygen. Rectal temperature was measured at hospital intake, prior to premedication, immediately after anesthetic induction, and every 5 minutes after anesthetic induction. Esophageal temperature was measured every 5 minutes during anesthesia, beginning 30 minutes after anesthetic induction. After anesthesia, dogs were covered with a warm-air blanket and rectal temperature was measured every 10 minutes until normothermia (37 degrees C) was achieved. RESULTS: Dogs in both treatment groups had lower rectal temperatures within 5 minutes after anesthetic induction and throughout anesthesia. Compared with dogs that received a benzodiazepine plus ketamine, dogs that received a benzodiazepine plus propofol had significantly lower rectal temperatures and the interval from discontinuation of anesthesia to achievement of normothermia was significantly longer. CONCLUSIONS AND CLINICAL RELEVANCE: Dogs in which anesthesia was induced with a benzodiazepine plus propofol or ketamine became hypothermic; the extent of hypothermia was more profound for the propofol combination. Dogs should be provided with adequate heat support after induction of anesthesia, particularly when a propofol-benzodiazepine combination is administered.
Long-term stability of ketamine hydrochloride 50mg/ml injection in 3ml syringes.[Pubmed:27107463]
Ann Pharm Fr. 2016 Jul;74(4):283-7.
INTRODUCTION: Ketamine hydrochloride (Ketalar((R))) injection is often used as a general anesthetic agent. It is particularly suited to short-term interventions. It can also be used as an inducer of anesthesia before the administration of other anesthetic agents. The aim of this study was to evaluate the stability of Ketamine hydrochloride in 3ml polypropylene syringes after storage for up to 180days at room temperature. METHOD: Syringes containing Ketamine hydrochloride (50mg/ml) were prepared and stored at room temperature (25 degrees C) for 180days. The concentrations were measured by validated ultra-performance liquid chromatography-diode array detection at 0, 7, 14, 28, 60, 84, 112, 140 and 180days. A degradation test was performed to evaluate the specificity of the analysis. At each time point, the pH, color and visible particles of each solution were also assessed. RESULTS: Degradation tests proved no interfering peaks with ketamine. All solutions were physically stable during the storage. The lower confidence limit of the concentration for these solutions remains superior to 90% of the initial concentration at this date as recommended by the Food and Drug Administration (FDA) until 180days (100%+/-2%). CONCLUSION: Solutions of ketamine (50mg/ml) were chemically stable for 180days in polypropylene syringes with storage at room temperature and could be prepared in advance by a centralized intravenous admixture service.
Effects of premedication with sustained-release buprenorphine hydrochloride and anesthetic induction with ketamine hydrochloride or propofol in combination with diazepam on intraocular pressure in healthy sheep.[Pubmed:26309105]
Am J Vet Res. 2015 Sep;76(9):771-9.
OBJECTIVE: To determine the effects of diazepam combined with Ketamine hydrochloride or propofol for induction of anesthesia (IOA) following premedication with sustained-release buprenorphine hydrochloride (SRB) on intraocular pressure (IOP) in sheep. ANIMALS: 20 healthy adult sheep. PROCEDURES: Diazepam with ketamine or propofol was given IV to each of 10 sheep after premedication with SRB (0.01 mg/kg, SC); after > 4 weeks, each sheep received the other induction combination with no premedication. For both eyes, IOPs were measured before premedication (if given), 10 minutes prior to (baseline) and immediately following administration of ketamine or propofol (time of IOA), after endotracheal intubation, and 5 minutes after IOA. Peak end-tidal P(CO2), globe position, and pupillary diameter were also analyzed. RESULTS: Data were not available for all sheep for all anesthetic episodes. Propofol-diazepam administration alone had no significant effect on IOP, whereas there was a significant decrease in IOP immediately following ketamine-diazepam administration alone. At 5 minutes after ketamine-diazepam administration, SRB-premedicated sheep had significantly higher IOP than unpremedicated sheep. Intraocular pressure was significantly higher at baseline, at intubation, and 5 minutes after IOA in SRB-premedicated sheep receiving propofol-diazepam, compared with unpremedicated sheep. Peak end-tidal P(CO2) at intubation was significantly higher in SRB-premedicated sheep. For sheep receiving either anesthetic treatment, IOPs did not differ significantly with or without SRB premedication. Globe position or pupillary diameter and IOP were not significantly related at any time point. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggested that both ketamine-diazepam and propofol-diazepam combinations were suitable for IOA without increasing IOP in sheep. The use of SRB should be avoided in sheep when increases in IOP are undesirable.
Effects of ketamine, a noncompetitive NMDA antagonist, on the acquisition of the lever-press response in rats.[Pubmed:7716221]
Physiol Behav. 1995 Feb;57(2):389-92.
We analyzed the effects of ketamine, a noncompetitive NMDA antagonist, on the acquisition of the lever-press response in the Skinner box and on motor performance both in the open field and in the inclined screen. Ninety-six adult male Wistar rats were assigned at random to eight different groups (n = 12). The first four groups received an acute intraperitoneal (IP) injection of: (a) physiological saline, (b) 4 mg/kg ketamine, (c) 8 mg/kg ketamine, or (d) 12 mg/kg ketamine, and the subjects were tested in a free lever-press response shaping in the Skinner box. The second four groups received the same substances and doses as the first four, but the subjects were tested for locomotor activity in an open field and tested immediately afterwards for motor performance in an 80 degrees inclined screen. Results showed that ketamine impaired the acquisition of the lever-press response in a dose-dependent manner, with no effects on ambulation in the open field nor on length of stay in the inclined screen. These results suggest that ketamine effects on the acquisition of the lever-press response cannot be attributed to a motor impairment, indicating a possible specific effect of ketamine on the associative learning acquisition.
The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate.[Pubmed:6317114]
Br J Pharmacol. 1983 Jun;79(2):565-75.
The interaction of two dissociative anaesthetics, ketamine and phencyclidine, with the responses of spinal neurones to the electrophoretic administration of amino acids and acetylcholine was studied in decerebrate or pentobarbitone-anaesthetized cats and rats. Both ketamine and phencyclidine selectively blocked excitation by N-methyl-aspartate (NMA) with little effect on excitation by quisqualate and kainate. Ketamine reduced responses to L-aspartate somewhat more than those of L-glutamate; the sensitivity of responses to these two putative transmitters was between that to NMA on one hand and that to quisqualate or kainate on the other. On Renshaw cells, ketamine and phencyclidine reduced responses to acetylcholine less than those to NMA but more than those to quisqualate or kainate. Dorsal root-evoked synaptic excitation of Renshaw cells was reduced to a greater extent than that following ventral root excitation. Intravenous ketamine, 2.5-20 mg/kg, and phencyclidine, 0.2-0.5 mg/kg, also selectively blocked excitation of neurones by NMA. Ketamine showed no consistent or selective effect on inhibition of spinal neurones by electrophoretically administered glycine or gamma-aminobutyricacid (GABA). The results suggest that reduction of synaptic excitation mediated via NMA receptors contributes to the anaesthetic/analgesic properties of these two dissociative anaesthetics.